Pharmacokinetics in patients with burns

Journal of Pharmacy Practice and Research

Volumn 35, Issue 1, 2005, Pages 53-55

  Cox, Ian R ^a  

^a ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; ANTIBIOTIC AGENT; ATRACURIUM; BENZODIAZEPINE DERIVATIVE; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CIMETIDINE; DIAZEPAM; FLUCONAZOLE; GENTAMICIN; GLYCOPEPTIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPENEM; LORAZEPAM; MIDAZOLAM; MIVACURIUM; MORPHINE; MUSCLE RELAXANT AGENT; RANITIDINE; SUXAMETHONIUM; TEICOPLANIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

BURN; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; HUMAN; PATHOPHYSIOLOGY; PHARMACOKINETICS; REVIEW;

EID: 18444379355     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2005.tb00302.x     Document Type: Review

References (21)

1. Jaehde U, Sorgel F. Clinical pharmacokinetics in patients with burns. Clin Pharmacokinet 1995; 29: 15-28.
2. Bonate PL. Pathophysiology and pharmacokinetics following burn injury. Clin Pharmacokinet 1990; 18: 118-30.
3. Martyn J. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology 1986; 65: 67-75.
4. Rolan PE. Plasma protein binding displacement interactions - why are they still regarded as clinically important? Br J Clin Pharmacol 1994; 37: 125-8.
5. MacLennan N, Heimbach DM, Cullen BF. Anesthesia for major thermal injury. Anesthesiology 1998; 89: 749-70.
6. Weinbren MJ. Pharmacokinetics of antibiotics in burn patients. J Antimicrob Chemother 1999; 44: 319-27.
7. Sampol E, Jacquet A, Viggiano M, Bernini V, Manelli JC, Lacarelle B, et al. Plasma, urine and skin pharmacokinetics of cefipime in burns patients. J Antimicrob Chemother 2000; 46: 315-7.
8. Weinbren MJ. Pharmacokinetics of antibiotics in burns patients [letter]. J Antimicrob Chemother 2001; 47: 720.
9. Hoey LL, Tschida SJ, Rotschafer JC, Guay DR, Vance-Bryan K. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries. J Burn Care Rehabil 1997; 18: 116-24.
10. Steer JA, Papini RP, Wilson AP, Dhillon S, Hickens MF, McGrouther DA, et al. Pharmacokinetics of a single dose of teicoplanin in burn patients. J Antimicrob Chemother 1996; 37: 545-53.
11. Podczeck F, Dhillon S, Wilson AP. The assessment of pharmacokinetic parameters of teicoplanin in burns comparing the methods of nonlinear curve fitting and quantified maximum entropy. Int J Pharm 1996; 142: 235-46.
12. Tett SE, Holford NH, McLachlan AJ. Population pharmacokinetics and pharmacodynamics: an underutilised resource. Drug Inf J 1998; 32: 693-710.
13. Vozeh S, Steimer JL, Rowland M, Morselli P, Mentre F, Balant LP, et al. The use of population pharmacokinetics in drug development. Clin Pharmacokinet 1996; 30: 81-93.
14. Boucher BA, King SR, Wandschneider HL, Hickerson WL, Hanes SD, Herring VL, et al. Fluconazole pharmacokinetics in burn patients. Antimicrob Agents Chemother 1998; 42: 930-3.
15. Marcyn JA, Bishop AL, Oliveri MF. Pharmacokinetics and pharmacodynamics of ranitidine after burn injury. Clin Pharmacol Ther 1992; 51: 408-14.
16. Furman WR, Munster AM, Cone EJ. Morphine pharmacokinetics during anesthesia and surgery in patients with burns. J Burn Care Rehabil 1990; 11: 391-4.
17. Herman RA, Veng-Pedersen P, Miotto J, Komorowski J, Kealey GP. Pharmacokinetics of morphine sulfate in patients with burns. J Burn Care Rehabil 1994; 15: 95-103.
18. Macfie AG, Magides AD, Reilly CS. Disposition of alfentanil in burns patients. Br J Anaesth 1992; 69: 447-50.
19. Martyn JA, Abernethy DR, Greenblatt DJ. Plasma protein binding of drugs after severe burn injury. Clin Pharmacol Ther 1984; 35: 535-9.
20. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors. Anesthesiology 1992; 76: 822-43.
21. Werba AE, Neiger FX, Bayer GS, Schultz AM, Maitz PK, Wolrab C. Pharmacodynamics of mivacurium in severely burned patients. Burns 1996; 22: 62-4.